Condition
Chemotherapy Effect clinical trials and research
As of November 12, 2026, Find a Trial lists 39 Chemotherapy Effect clinical trials that are recruiting, at sites in 14 countries (most in China (21), United States (3), Netherlands (2)). By phase: Phase 3 (14), Phase 2 (7), Phase 4 (1). The most active sponsors are Sixth Affiliated Hospital, Sun Yat-sen University (5), Sun Yat-sen University (3), Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 39Clinical trials
- 14Countries
Newest Chemotherapy Effect clinical trials
All recruiting trials (39)
-
Adding silibinin to standard daunorubicin or idarubicin therapy for newly diagnosed non‑M3 acute myeloid leukemia
This trial will test whether adding silibinin (a liver‑protecting compound) to standard daunorubicin or idarubicin chemotherapy helps people with newly diagnosed non‑M3 acute myeloid leukemia.
-
Camrelizumab plus apatinib with or without FOLFOX chemotherapy for advanced liver cancer
This research will test whether adding FOLFOX chemotherapy to camrelizumab plus apatinib helps adults with advanced hepatocellular carcinoma who have not received prior systemic treatment.
-
Personalized management for borderline resectable and locally advanced pancreatic cancer
This study is testing if giving chemotherapy first can help people with borderline resectable and locally advanced pancreatic cancer have surgery and improve their chances of survival.
-
Impact of massage therapy on sleep in young cancer patients
This study is testing whether personalized massage therapy can help young cancer patients in the hospital sleep better and feel less tired, anxious, and in pain during their treatment.
-
Comparing treatments for oral mucositis in children undergoing chemotherapy
This study tests whether sodium bicarbonate, saline, or black mulberry syrup can help reduce mouth sores in children aged 6-18 who are getting chemotherapy.
-
Assessing long-term dental effects of chemotherapy in childhood cancer survivors
This study looks at the long-term dental health of childhood cancer survivors who had chemotherapy to see if they have more dental problems compared to kids who didn’t have cancer.
-
Perioperative oxaliplatin plus S-1 with H. pylori eradication for locally advanced gastric and gastroesophageal junction adenocarcinoma
This trial tests whether adding a 14-day H. pylori eradication regimen to perioperative oxaliplatin plus S-1 chemotherapy helps people with H. pylori–positive resectable locally advanced gastric or gastroesophageal junction cancer.
-
Predicting how well chemotherapy will work for esophageal cancer patients
This study is testing if DNA changes in biopsy samples can help doctors predict how well chemotherapy will work for patients with esophageal cancer, so those who might not benefit can avoid unnecessary treatment.
-
Predicting how well gastric cancer patients respond to chemotherapy using AI
This study tests if using AI to combine imaging and tissue data can help predict how well advanced gastric cancer patients will respond to chemotherapy.
-
Combining liver-directed therapy (HAI pump or SIRT) with GemOx chemotherapy for unresectable intrahepatic cholangiocarcinoma (TOMCAT)
This trial will test whether adding a liver-directed treatment (either a hepatic artery infusion pump delivering floxuridine or selective internal radiation therapy) to GemOx chemotherapy helps shrink or control intrahepatic cholangiocarcinoma that cannot be removed by surgery.
-
Evaluating anti-EGFR therapy effectiveness in specific colorectal cancer patients
This study is testing if a personalized treatment approach using anti-EGFR therapy can help people with left-sided RAS-wild type metastatic colorectal cancer do better than standard chemotherapy.
-
Comparing two treatment methods for advanced liver cancer
This study is testing two different treatment methods for advanced liver cancer to see which one helps patients feel better and live longer.
-
Comparing chemotherapy and surgery for rectal cancer after local resection
This study is testing whether chemotherapy or surgery works better for people with intermediate-risk rectal cancer who have already had part of their tumor removed.
-
Comparing two treatment approaches for liver cancer
This study is testing two different treatment plans for liver cancer to see which one helps patients live longer and have better outcomes.
-
Comparing two treatments for metastatic hormone-sensitive prostate cancer
This study is testing if adding chemotherapy to a hormone treatment can help men with advanced prostate cancer live longer compared to just using hormone treatment alone.
-
Using a smartphone brain-training app to reduce chemo‑brain in gynecologic cancer patients
This will test whether a mobile cognitive training app can reduce chemo‑brain symptoms in people with gynecologic cancers who are receiving chemotherapy.
-
Neoadjuvant therapy followed by local treatment for recurrent colorectal liver metastases
This study is testing if giving a new treatment before local therapy can help people with recurrent colorectal liver cancer live longer compared to getting local therapy right away.
-
Comparing chemotherapy and observation for liver metastasis in colorectal cancer
This study is testing if some patients with liver metastasis from colorectal cancer can safely skip chemotherapy after surgery and just be monitored instead.
-
Comparing sequential S-1 therapy after surgery for advanced gastric cancer
This study is testing if a specific treatment plan using S-1 therapy after surgery can help people with advanced stomach cancer recover better.
-
Combining targeted therapy with chemotherapy for advanced colorectal cancer
This study is testing if adding a targeted therapy to standard chemotherapy can help people with advanced colorectal cancer live longer without their cancer coming back after surgery.
-
Comparing two treatment approaches for esophageal squamous cell carcinoma
This study is testing whether adding extra chemotherapy to standard treatment can help people with inoperable esophageal squamous cell carcinoma live longer and feel better.
-
Understanding biomarkers in metastatic colorectal cancer treatment
This study is trying to see how cancer changes during treatment in people with metastatic colorectal cancer and whether certain genetic markers can help tailor better treatment options for them.
-
Effects of socio-aesthetic care on anxiety in cancer patients undergoing chemotherapy
This study tests if special care focused on appearance and social support can help reduce anxiety in cancer patients going through chemotherapy.
-
Using metronomic temozolomide for patients with advanced neuroendocrine tumors who are unfit for standard treatments
This study is testing if a continuous low-dose chemotherapy called metronomic temozolomide can help people with advanced neuroendocrine tumors who can't tolerate standard treatments feel better and live longer.
-
Using Simvastatin to Improve Treatment for Triple Negative Breast Cancer
This study is testing if adding simvastatin to chemotherapy can help women with advanced triple-negative breast cancer respond better to treatment.
-
Implementation program for advanced pancreatic cancer care
This program is testing new ways to improve treatment and survival rates for people with locally advanced pancreatic cancer in the Netherlands by using the best practices from around the world.
-
Using magnetic markers to locate breast cancer and lymph nodes after chemotherapy
This study is testing if using tiny magnetic seeds can help doctors find and remove breast cancer and lymph nodes more accurately in patients after they have chemotherapy.
-
Testing drug sensitivity in micro tumors to guide treatment for colorectal cancer
This study is testing whether a new 3D drug sensitivity test on tiny tumors can help guide better treatment decisions for people with colorectal cancer after surgery.
-
Assessing survival and quality of life in patients with advanced pancreatic cancer
This study looks at how long people with advanced pancreatic cancer live and how their quality of life is affected while being treated at different hospitals in the Nordic region.
-
Evaluating tumor cell characteristics in breast cancer patients
This study is testing if tracking certain tumor cells in breast cancer patients can help predict how well they respond to treatment after chemotherapy and surgery.
-
Using capecitabine to reduce breast cancer recurrence in high-risk patients
This study is testing if the drug capecitabine can help reduce the chances of breast cancer coming back in women aged 18-70 who are at high risk after surgery.
-
Examining brain changes in colorectal cancer patients undergoing chemotherapy
This study is trying to see how chemotherapy affects thinking and memory in people with colorectal cancer.
-
Combination of chemotherapy and immunotherapy for advanced esophagogastric junction cancer
This study is testing if combining a new immune therapy with chemotherapy can help people with advanced esophagogastric junction cancer have smaller tumors that are easier to remove and improve their chances of living longer.
-
Neoadjuvant treatments for esophageal cancer
This study is testing different combinations of treatments for people with esophageal cancer to see if they can improve outcomes compared to just having surgery.
-
Chemoradiotherapy for esophageal and esophagogastric junction cancer
This study is testing a new combination of chemotherapy, radiation, and immune therapies to see if it helps people with advanced esophageal or esophagogastric junction cancer live longer and feel better.
-
Using topotecan and melphalan to treat retinoblastoma
This study is testing if giving the chemotherapy drugs topotecan and melphalan directly into the eye can effectively treat retinoblastoma while saving the eye from removal.
-
Neoadjuvant chemotherapy for gastric cancer using oxaliplatin and S-1
This study is testing if a combination of two drugs, oxaliplatin and S-1, can help people with advanced stomach cancer by shrinking their tumors before surgery.
-
Combining Gemcitabine and Celecoxib for Pancreatic Cancer Treatment
This study is testing if adding celecoxib to gemcitabine can help people who have had surgery for pancreatic cancer live longer and stay cancer-free.
-
Using HIPEC for advanced ovarian cancer treatment during surgery
This study is testing whether a special type of heated chemotherapy given during surgery can help people with advanced ovarian cancer live better and longer after their treatment.
Related topics
Quick answers
How many Chemotherapy Effect clinical trials are recruiting right now?
39, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in China (21 trials), United States (3 trials), Netherlands (2 trials), Sweden (2 trials), Norway (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 14, Phase 2: 7, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.